Blog Entry List
the Medicaid and NC Health Choice programs cover filgrastim-ayow injection, for subcutaneous or intravenous use
Medicaid and NC Health Choice programs cover nivolumab and relatlimab-rmbw injection
Medicaid and NC Health Choice programs cover difelikefalin injection, for intravenous use
Medicaid and NC Health Choice programs cover sutimlimab-jome injection, for intravenous use
Designed to improve communication access for Medicaid and NC Health Choice beneficiaries who are Deaf, Deaf-Blind and Hard of Hearing
Qualifying Medicaid Standard Plan members in 33 North Carolina counties may receive housing and transportation services.
WellCare broker update, contracting with transportation brokers, emergent care reminder
Data and clarifications on the DCW One-Time Bonus
This information replaces the reimbursement guidelines posted in the December 2019 bulletin.
Billing Reimbursement for second booster
Billing Guideline for use of Evusheld
Capacity building FAQs, guidance on the use of extenders, standard terms and conditions, and Provider Manual updates.
NC Medicaid received approval to increase NC Innovations Waiver capacity by 1,000 slots.
Approved for beneficiaries over the age of 21, effective July 1, 2021
The Medicaid NCCI edits for the most recent quarter are published on the CMS website.